Sage Therapeutics, Inc. (SAGE) News
Sage Therapeutics, Inc. (SAGE)
Today's Latest Price: $42.92 USD
Updated Jul 10 4:00pm
Add SAGE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
Filter SAGE News Items
SAGE News Results
| Event/Time | Symbol | Company | News Detail | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest SAGE News From Around the Web
Below are the latest news stories about Sage Therapeutics Inc that investors may wish to consider to help them evaluate SAGE as an investment opportunity.
Edited Transcript of SAGE earnings conference call or presentation 7-May-20 8:30pm GMTQ1 2020 SAGE Therapeutics Inc Earnings Call |
Neurocrine Adds to Pipeline With $2 Billion Takeda DealBiotech gets 7 drugs in partnership, 3 of which are in phase 2 testing Continue reading... |
Sage Therapeutics (SAGE) Presents At Goldman Sachs Global Healthcare Conference - SlideshowThe following slide deck was published by Sage Therapeutics, Inc. in conjunction with this event.... |
Is There Any Hope Left for Sage Therapeutics?The company, which failed pivotal clinical trials investigating major depression, aims to reverse its fortunes this year. |
Sage Therapeutics to Present at Goldman Sachs 41st Annual Global Healthcare ConferenceSage Therapeutics, Inc. (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Wednesday, June 10, 2020 at 3:00 p.m. ET. |
Sage Therapeutics Inc (SAGE) Q1 2020 Earnings Call TranscriptLadies and gentlemen, thank you for standing by, and welcome to the Sage Therapeutics Announced First Quarter 2020 Financial Results Conference Call. Hello, and thank you for joining Sage Therapeutics' First Quarter 2020 Financial Results Conference Call. Please consult the risk factors discussed in today's press release, and in our SEC filings for additional details. |
Sage Therapeutics to Present at Bank of America Health Care Conference 2020Sage Therapeutics, Inc. (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that the Company will present at the Bank of America Health Care Conference 2020 on Wednesday, May 13, 2020 at 1:40 p.m. ET. |
Sage Therapeutics Announces First Quarter 2020 Financial Results and Highlights Pipeline and Business ProgressToday, Sage Therapeutics, Inc. (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, reported business highlights and financial results for the first quarter ended March 31, 2020. The Company also announced the promotion of Mike Cloonan to chief operating officer; he will continue to report into Jeff Jonas, Sage’s chief executive officer. In the newly created role, Mr. Cloonan will strategically align the business functions to support the ongoing development and commercialization of Sage’s brain health portfolio. |
One Biotech Stock For 2020FDA has just fast-tracked research on an exciting new mental health treatment, and one small company is making moves to secure its place as an early mover in this revolution |
Sage Therapeutics to Report First Quarter 2020 Financial Results on Thursday, May 7, 2020Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Thursday, May 7, 2020, at 4:30 p.m. EDT to announce first quarter 2020 financial results and discuss recent business updates. |
